Vedder Price P.C.
Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor
Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
DEUTSCHES KREBSFORSCHUNGSZENTRUM RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
A C A A A A A A A
A61P C12N A61P A61K A61K A61K A61K A61K A61K
inventional additional inventional inventional inventional inventional inventional inventional inventional
Lea Karsten Jean Junwei Antonio
Schroeder Geletneky Rommelaere Li Marchini